Table I.
Postoperative side effects.
| Group MC (n=8) | Group MD1 (n=8) | Group MD2 (n=8) | Group FC (n=8) | Group FD1 (n=8) | Group FD2 (n=8) | |
|---|---|---|---|---|---|---|
| Nausea and vomiting | 5 | 3 | 0 | 4 | 2 | 1 |
| Chills | 3 | 1 | 0 | 2 | 1 | 0 |
| Respiratory depression | 0 | 0 | 0 | 0 | 0 | 0 |
Group MC/FC, male/female controlled group received placebo + remifentanil (0.2 µg.kg−1.min−1); Group MD1/FD1, male/female group, received low-dose dexmedetomidine (0.2 µg.kg−1) + remifentanil (0.2 µg.kg−1.min−1); Group MD2/FD2, male/female group received high-dose dexmedetomidine (0.6 µg.kg−1) + remifentanil (0.2 µg.kg−1.min−1)